SearcharxivSearch

arXiv subjects

Melda Yeghaian

Publications and source records attributed to Melda Yeghaian.

2 recordsLinked to original sources

Decorrelation Speeds Up Vision Transformers

Masked Autoencoder (MAE) pre-training of vision transformers (ViTs) yields strong performance in low-label data regimes but comes with substantial computational costs, making it impractical in time- and resource-constrained industrial settings. We address this by integrating Decorrelated Backpropagation (DBP) into MAE pre-training, an optimization method that iteratively reduces input correlations at each layer to accelerate convergence. Applied selectively to the encoder, DBP achieves faster pre-training without loss of stability. To mimic constrained-data scenarios, we evaluate our approach on ImageNet-1K pre-training and ADE20K fine-tuning using randomly sampled subsets of each dataset. Under this setting, DBP-MAE reduces wall-clock time to baseline performance by 21.1%, lowers carbon emissions by 21.4%, and improves segmentation mIoU by 1.1 points. We observe similar gains when pre-training and fine-tuning on proprietary industrial data, confirming the method's applicability in real-world scenarios. These results demonstrate that DBP can reduce training time and energy use while improving downstream performance for large-scale ViT pre-training. Keywords: Deep learning, Vision transformers, Efficient AI, Decorrelation

cs.CV

Multimodal Integration of Longitudinal Noninvasive Diagnostics for Survival Prediction in Immunotherapy Using Deep Learning

Purpose: Immunotherapies have revolutionized the landscape of cancer treatments. However, our understanding of response patterns in advanced cancers treated with immunotherapy remains limited. By leveraging routinely collected noninvasive longitudinal and multimodal data with artificial intelligence, we could unlock the potential to transform immunotherapy for cancer patients, paving the way for personalized treatment approaches. Methods: In this study, we developed a novel artificial neural network architecture, multimodal transformer-based simple temporal attention (MMTSimTA) network, building upon a combination of recent successful developments. We integrated pre- and on-treatment blood measurements, prescribed medications and CT-based volumes of organs from a large pan-cancer cohort of 694 patients treated with immunotherapy to predict mortality at three, six, nine and twelve months. Different variants of our extended MMTSimTA network were implemented and compared to baseline methods incorporating intermediate and late fusion based integration methods. Results: The strongest prognostic performance was demonstrated using a variant of the MMTSimTA model with area under the curves (AUCs) of $0.84 \pm $0.04, $0.83 \pm $0.02, $0.82 \pm $0.02, $0.81 \pm $0.03 for 3-, 6-, 9-, and 12-month survival prediction, respectively. Discussion: Our findings show that integrating noninvasive longitudinal data using our novel architecture yields an improved multimodal prognostic performance, especially in short-term survival prediction. Conclusion: Our study demonstrates that multimodal longitudinal integration of noninvasive data using deep learning may offer a promising approach for personalized prognostication in immunotherapy-treated cancer patients.

cs.LG